• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Veradigm Inc.

    2/13/26 1:08:01 PM ET
    $MDRX
    EDP Services
    Technology
    Get the next $MDRX alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 2)


    Veradigm Inc.

    (Name of Issuer)


    Common Stock, par value $0.01 per share

    (Title of Class of Securities)


    01988P108

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    01988P108


    1Names of Reporting Persons

    TD SECURITIES (USA) LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,137,354.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,137,354.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,137,354.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    1.1 %
    12Type of Reporting Person (See Instructions)

    BD


    SCHEDULE 13G

    CUSIP No.
    01988P108


    1Names of Reporting Persons

    Toronto Dominion Holdings USA Inc
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    0.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    01988P108


    1Names of Reporting Persons

    TD Group US Holdings LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    0.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP No.
    01988P108


    1Names of Reporting Persons

    Toronto Dominion Bank
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CANADA (FEDERAL LEVEL)
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    5,900,520.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    5,900,520.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,900,520.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.5 %
    12Type of Reporting Person (See Instructions)

    FI


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Veradigm Inc.
    (b)Address of issuer's principal executive offices:

    222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO, ILLINOIS 60654
    Item 2. 
    (a)Name of person filing:

    TD SECURITIES (USA) LLC Toronto Dominion Holdings USA Inc TD Group US Holdings LLC Toronto Dominion Bank
    (b)Address or principal business office or, if none, residence:

    ONE VANDERBILT AVENUE NEW YORK, New York 10017 The address of TD Securities (USA) LLC's ("TDS") principal office, Cowen Financial Products LLC's ("CFP") principal office, and Toronto Dominion Holdings USA Inc.'s ("TDH") principal office is 1 Vanderbilt Avenue, New York, New York 10017. The address of TD Group US Holdings LLC's ("TD GUS") principal office is 251 Little Falls Drive, Wellington, Delaware 19808. The address of Toronto Dominion Bank's ("TD Bank") principal office is Toronto-Dominion Centre, 66 Wellington Street West, 12th Floor, TD Tower, Toronto, Ontario, Canada M5K 1A2.
    (c)Citizenship:

    TD SECURITIES (USA) LLC - DELAWARE Toronto Dominion Holdings USA Inc - DELAWARE TD Group US Holdings LLC - DELAWARE Toronto Dominion Bank - CANADA (FEDERAL LEVEL)
    (d)Title of class of securities:

    Common Stock, par value $0.01 per share
    (e)CUSIP No.:

    01988P108
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Bank
    Item 4.Ownership
    (a)Amount beneficially owned:

    7,037,874
    (b)Percent of class:

    6.6  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    TD SECURITIES (USA) LLC - 1,137,354 Toronto Dominion Holdings USA Inc - 0 TD Group US Holdings LLC - 0 Toronto Dominion Bank - 5,900,520

     (ii) Shared power to vote or to direct the vote:

    TD SECURITIES (USA) LLC - 0 Toronto Dominion Holdings USA Inc - 0 TD Group US Holdings LLC - 0 Toronto Dominion Bank - 0

     (iii) Sole power to dispose or to direct the disposition of:

    TD SECURITIES (USA) LLC - 1,137,354 Toronto Dominion Holdings USA Inc - 0 TD Group US Holdings LLC - 0 Toronto Dominion Bank - 5,900,520

     (iv) Shared power to dispose or to direct the disposition of:

    TD SECURITIES (USA) LLC - 0 Toronto Dominion Holdings USA Inc - 0 TD Group US Holdings LLC - 0 Toronto Dominion Bank - 0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    TD Securities (USA) LLC
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    TD SECURITIES (USA) LLC
     
    Signature:Christina Petrou
    Name/Title:Christina Petrou / Executive Vice President & Chief Operating Officer
    Date:02/13/2026
     
    Toronto Dominion Holdings USA Inc
     
    Signature:Christina Petrou
    Name/Title:Christina Petrou / Executive Vice President & Chief Operating Officer
    Date:02/13/2026
     
    TD Group US Holdings LLC
     
    Signature:Andre Ramos
    Name/Title:Andre Ramos / US Chief Financial Officer
    Date:02/13/2026
     
    Toronto Dominion Bank
     
    Signature:Christina Petrou
    Name/Title:Christina Petrou / Executive Vice President & Chief Operating Officer
    Date:02/13/2026
    Exhibit Information

    Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock of Veradigm Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: February 13, 2026 TD SECURITIES (USA) LLC By: /s/ Christina Petrou Title: Executive Vice President & Chief Operating Officer TORONTO DOMINION HOLDINGS USA INC. By: /s/ Christina Petrou Title: Executive Vice President & Chief Operating Officer TD GROUP US HOLDINGS LLC By: /s/ Andre Ramos Title: US Chief Financial Officer THE TORONTO-DOMINION BANK By: /s/ Christina Petrou Title: Executive Vice President & Chief Operating Officer

    Get the next $MDRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDRX

    DatePrice TargetRatingAnalyst
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    1/3/2024$11.00Equal Weight
    Barclays
    7/6/2023Buy → Hold
    Argus
    4/12/2023$13.00Equal-Weight
    Stephens
    2/1/2023$17.00 → $18.50Overweight → Neutral
    Piper Sandler
    12/7/2022$26.00Hold → Buy
    Argus
    11/9/2022$22.00 → $23.00Neutral → Buy
    Goldman
    11/4/2022$17.00Overweight
    Piper Sandler
    More analyst ratings

    $MDRX
    SEC Filings

    View All

    Veradigm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Veradigm Inc. (0001124804) (Filer)

    2/17/26 4:10:26 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Veradigm Inc.

    SCHEDULE 13G/A - Veradigm Inc. (0001124804) (Subject)

    2/13/26 1:08:01 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form 8-A12G/A filed by Veradigm Inc.

    8-A12G/A - Veradigm Inc. (0001124804) (Filer)

    2/2/26 4:47:45 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Veradigm downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Veradigm from Buy to Hold and set a new price target of $10.00 from $15.00 previously

    3/19/24 7:50:39 AM ET
    $MDRX
    EDP Services
    Technology

    Barclays initiated coverage on Veradigm with a new price target

    Barclays initiated coverage of Veradigm with a rating of Equal Weight and set a new price target of $11.00

    1/3/24 8:00:02 AM ET
    $MDRX
    EDP Services
    Technology

    Veradigm downgraded by Argus

    Argus downgraded Veradigm from Buy to Hold

    7/6/23 9:00:49 AM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Chief HR Officer Hammond Lisa was granted 58,140 shares, increasing direct ownership by 50% to 174,175 units (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    6/5/25 5:28:24 PM ET
    $MDRX
    EDP Services
    Technology

    SVP General Counsel Vakharia Tejal was granted 69,768 shares, increasing direct ownership by 22% to 387,476 units (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    6/5/25 5:22:40 PM ET
    $MDRX
    EDP Services
    Technology

    Director Sacks Jonathan S was granted 46,512 shares and converted options into 8,696 shares (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    6/3/25 9:28:21 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Veradigm to Release Business Update May 26th and Host Investor Call May 27th

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on Tuesday, May 26, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update on Wednesday, May 27th, at 8:00 a.m. Eastern Time. Update Call Details Veradigm plans to issue a press release after the close of regular stock market hours on Tuesday, May 26, 2026. The announcement will also be available at Veradigm investor relations website. To listen to the conference call on Wednesday, May 27, 2026 at 8:00 a.m. East

    5/26/26 8:01:00 AM ET
    $MDRX
    EDP Services
    Technology

    Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the availability of the Veradigm Health Network Architecture™ to early adopter customers. Veradigm Health Network Architecture provides independent practices a single real-time view of their clinical, financial, and operational performance and helps close a capability gap that has historically separated independent practices from large health systems. It connects data across the products practices already use, from EHR and practice management to clearinghouse and patient portal. Instead of overnight batch cycles and manual data stitching, information flows together as

    5/6/26 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that it has been recognized by KLAS in the 2026 Points of Light Award program for a collaborative initiative that embedded payer-derived social determinants of health (SDOH) data directly into provider EHR workflows. The recognition, awarded as part of the KLAS K2 Collaborative, highlights a multi-organization effort involving Veradigm, a national health plan serving 27 million members, and Raleigh Durham Medical Group, an independent provider group in North Carolina. Using the Veradigm Payer Insights (VPI) platform, the initiative embedded SDOH-triggered clinical re

    4/28/26 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4) (Amendment)

    4/A - Veradigm Inc. (0001124804) (Issuer)

    3/15/24 5:16:45 PM ET
    $MDRX
    EDP Services
    Technology

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    3/4/24 9:50:46 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Financials

    Live finance-specific insights

    View All

    Veradigm to Release Business Update May 26th and Host Investor Call May 27th

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on Tuesday, May 26, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update on Wednesday, May 27th, at 8:00 a.m. Eastern Time. Update Call Details Veradigm plans to issue a press release after the close of regular stock market hours on Tuesday, May 26, 2026. The announcement will also be available at Veradigm investor relations website. To listen to the conference call on Wednesday, May 27, 2026 at 8:00 a.m. East

    5/26/26 8:01:00 AM ET
    $MDRX
    EDP Services
    Technology

    Veradigm to Release Business Update February 17th and Host Investor Call February 18th

    Veradigm® (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the close of regular stock market hours on Tuesday, February 17, 2026. The announcement will also be available at Veradigm investor relations website. To listen to the conference call, participants may log onto the Veradigm invest

    2/10/26 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    Veradigm Amends and Extends Stockholder Rights Plan

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires bene

    8/20/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Veradigm Inc.

    SC 13G - Veradigm Inc. (0001124804) (Subject)

    11/14/24 4:05:58 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/14/24 1:11:13 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/8/24 10:29:29 AM ET
    $MDRX
    EDP Services
    Technology

    $MDRX
    Leadership Updates

    Live Leadership Updates

    View All

    Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director

    Veradigm® India Private Limited, the India subsidiary of Veradigm (OTC:MDRX), a US-based leader in clinical and revenue cycle solutions for independent practices, today announced a major expansion of its Pune operations, doubling its office capacity and adding a new managing director. This milestone marks a significant chapter in Veradigm's growth journey, reflecting the company's continued investment in its people, its infrastructure, and its long-term vision for India. Located in one of Pune's prime business districts, the expansion is designed to support scale, inspire collaboration, and create an environment where teams can do their best work. It is a direct expression of Veradigm's f

    4/27/26 10:31:00 PM ET
    $MDRX
    EDP Services
    Technology

    Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

    Veradigm Inc. (OTC:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chief Financial Officer of the Company, effective on the later of May 11, 2026 and the first business day after Veradigm files its Annual Report on Form 10-K for its 2023 and 2024 fiscal years, or as otherwise agreed. Mr. Greyenbuhl is a seasoned operator and finance executive with more than 25 years of experience across both global public and private companies. He brings a strong track record as a general manager and operator, having served as general manager of businesses of Automatic Data Processing, Inc. ("ADP") on two occ

    4/6/26 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

    Healthcare IT Veteran - former AWS and Cerner senior executive - to lead and accelerate innovation across Veradigm's unique footprint Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer. Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and interoperability elevated to enterprise grade - capabilities trusted by providers, payers, bioph

    11/3/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology